Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA)

69 filings reported holding TSHA - Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value as of Q4 2021.
Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,503,286 shares of 274,772,727 outstanding shares and own 6.73% of the company stock.
Largest 10 shareholders include FMR LLC (4,280,494 shares), BlackRock Inc. (3,032,963 shares), Nantahala Capital Management, LLC (1,456,147 shares), FRANKLIN RESOURCES INC (1,308,533 shares), UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (1,147,040 shares), Artal Group S.A. (1,040,882 shares), VANGUARD GROUP INC (883,647 shares), Sands Capital Ventures, LLC (724,873 shares), TimesSquare Capital Management, LLC (659,100 shares), and Alphabet Inc. (640,882 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.